FMC explores strategic options including sale; Q4 net loss $1.72B on impairment

FMC CORP

Board authorized exploration of strategic options including a sale to unlock shareholder value.
Q4 2025 revenue $1.08B (-12% YoY); full year revenue $3.47B (-18%).
Q4 GAAP net loss $1.72B ($13.74 loss per diluted share) driven by non-cash goodwill impairment.
FY 2026 revenue guidance $3.60-3.80B; Adjusted EPS $1.63-1.89; free cash flow near zero.
Plans to pay down $1B debt through asset sales and licensing; new active ingredient sales target $300-400M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.